Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ellis

Showing results (1101-1110 of 1,178) with videos related to

Pageof 118
Sort By:
Urology Practice|October 25, 2024
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community PracticeFranklin D Gaylis, Michael S Leapman, Shellie D Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Design, structure-activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitorsJeffrey G Varnes, Dean A Wacker, Irina C Jacobson, et al.
Transplantation|January 11, 2000
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppressionR Shapiro, M Nalesnik, J McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integraseJeffrey Y Melamed, Melissa S Egbertson, Sandor Varga, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patientsSaul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapyL T Bacheler, E D Anton, P Kudish, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|December 1, 2000
An integrated confocal and magnetic resonance microscope for cellular researchR A Wind, K R Minard, G R Holtom, et al.
The Journal of Invasive Cardiology|June 5, 2003
Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventionsDavid E Allie, Mitchell D Lirtzman, Charles H Wyatt, et al.
Cancer Research|May 17, 2003
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancerAlison M Dunning, Peter D Ellis, Simon McBride, et al.
Family Practice|August 22, 2022
Implementing a home-based virtual hypertension programme-a pilot feasibility studyAditi Gupta, Shellie D Ellis, Crystal Burkhardt, et al.
Pageof 118

Showing results (1101-1110 of 1,178) with videos related to

Sort By:
Pageof 118
Urology Practice|October 25, 2024
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community PracticeFranklin D Gaylis, Michael S Leapman, Shellie D Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Design, structure-activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitorsJeffrey G Varnes, Dean A Wacker, Irina C Jacobson, et al.
Transplantation|January 11, 2000
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppressionR Shapiro, M Nalesnik, J McCauley, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2008
Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integraseJeffrey Y Melamed, Melissa S Egbertson, Sandor Varga, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patientsSaul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapyL T Bacheler, E D Anton, P Kudish, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|December 1, 2000
An integrated confocal and magnetic resonance microscope for cellular researchR A Wind, K R Minard, G R Holtom, et al.
The Journal of Invasive Cardiology|June 5, 2003
Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventionsDavid E Allie, Mitchell D Lirtzman, Charles H Wyatt, et al.
Cancer Research|May 17, 2003
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancerAlison M Dunning, Peter D Ellis, Simon McBride, et al.
Family Practice|August 22, 2022
Implementing a home-based virtual hypertension programme-a pilot feasibility studyAditi Gupta, Shellie D Ellis, Crystal Burkhardt, et al.
Pageof 118